New Drug To Prevent Life-Threatening Side Effects Including Sudden Death In CKD & Dialysis Patients
For most Chronic Kidney Disease and Dialysis patients, Hyperkalemia (high potassium), is a common term since Chronic Kidney Disease patients are among the highest risk group for the disorder. It is an unfortunate fact that "high levels of potassium in the blood can be deadly," reported Medical News Today. However, a very promising drug, Patiromer, could change this since it has proven to significantly lower potassium levels in Chronic Kidney Disease and Dialysis patients.
Recommended Reading: Too much potassium (hyperkalemia) is dangerous for CKD Patients' Heart Health
Hyperkalemia can cause life-threatening Cardiac Arrhythmia (a disturbance in the regular rhythm of your heartbeat) and sudden death. Moreover, sudden cardiac death is the single most common form of death in Dialysis patients, accounting for 20% to 30% of all deaths," declared a report published by the American Heart Association, Inc. According to Dr. George Bakris (University of Chicago Medicine), the side effects of Hyperkalemia "affects everyone with stage 4 or 5 Chronic Kidney Disease, almost 1 million people in the United States.”
Patiromer offers a world-class alternative as the first of its kind treatment to reduce mild Hyperkalemia (between 5.0 mmol/L and 5.5 mmol/L) and moderate Hyperkalemia (greater than 5.5 mmol/L) quickly bringing potassium levels back to normal and keeping them there to prevent life-threatening adverse events. After a long-term study the Journal of the American Medical Association found that, Patiromer decreased potassium levels within 48 hours.
Newswise suggested that the only alternative is a 50-year-old drug that is difficult for Chronic Kidney Disease and Dialysis patients to take, poorly tolerated and unpredictable. Dr. Bakris said, “Most patients won’t take it.” On the other hand, when this new medication is mixed with a few tablespoons of water and ingested, "particles attach themselves to potassium ions in the lower part of the colon, where the concentration of free potassium is the highest. The potassium-packed beads are then excreted."
Recommended Reading: The Next Big Health Marvel For People With Chronic Kidney Disease
What a great advancement in the Chronic Kidney Disease Community, wouldn't you agree? Patiromer is in Phase 2 Trials to establish its effectiveness, which means it is one step away from Final Confirmation and Food and Drug Administration approval.
Recommended Reading: Fruits And Vegetables That Are Acceptable For Chronic Kidney Disease Patients
Would you try Patiromer to better control your elevated potassium levels? Share your response with the over 24,500 Friends who have Liked the KidneyBuzz.com Facebook Fan Page by clicking here. While you are there, join the community and Like the page as well! Also, visit KidneyBuzz.com every day for the latest Breaking News and Information which teaches those with Chronic Kidney Disease, Diabetes, and Hypertension how to better manage and Improve their lives.